- Home
- Skin Care Products Industry
- Biotherapeutic Market and Forecasts, May 2013
Industries
- Skin Care Products (50)
- Biopharmaceutical (38)
- Drug and Medication (14)
- Biotechnology (13)
- Pathology (11)
-
- Blood Supply, Tissue Banking and Transplantation (6)
- Biological Therapy (5)
- Drug Delivery Technology (3)
- Genomics (3)
- Medical Equipment and Supply (3)
- Pharmaceutical (3)
- Chemical and Material (2)
- Drug Discovery and Development (2)
- Investment Banking (2)
- Nutraceutical (2)
- Cleantech (1)
- Cosmetic Surgery (1)
- Diagnostics (1)
- Energy & Environment (1)
- Generic Drug (1)
Top countries
Publication dates
All regions
data types
- All
- Company Data (327)
- Industry Data
- Country Data (36)
Biotherapeutic Market and Forecasts, May 2013
You might be interested in: clinical trial, cancer, biotherapeutics, more »
industry reports
country reports
U.S. Biotechnology Industry Brief
- Industry report
- April 2012
- 4 pages
... A wining cgmp facility design for manufacturing of biotherapeutics biological products commercialization process commercialization of biotherapeutics products is a complex process which starts ...
- Industries: Biotechnology
- Countries: United States
U.S. Biotechnology Industry Brief
- Industry report
- April 2012
- 4 pages
... Of biotherapeutics products is a complex process which starts from mammalian cell line development and engineering and going through various phases of development such as early stage process ...
- Industries: Biotechnology
- Countries: United States
Biosimilar Market Analysis in The United States and Japan
- Industry report
- May 2013
- 62 pages
... Management plan is fundamental for all biotherapeutic products since even minor differences in the manufacturing process may affect the efficacy and/or safety profile Innovator products Biosimilar may ...
- Industries: Biopharmaceutical
- Countries: United States, Japan
Pharmaceutical Sector in The United States and Israel
- Industry report
- December 2011
- 6 pages
- by Corporation
... Event reported): december 1, 2011 protalix biotherapeutics, inc. (Exact name of registrant as specified in its charter) florida 001-33357 65-0643773 (state or other jurisdiction (commission file ...
- Industries: Pharmaceutical
- Countries: United States, Israel, World
Biotechnology Market in The United States and China
- Industry report
- August 2011
- 14 pages
... Are the most popular host system for the production of bio- therapeutics in the biotechnology and pharmaceu- tical industries [1]. Currently, 60 70% Of all recom- binant biotherapeutics are produced in cho cells ...
- Industries: Biotechnology
- Countries: United States, China
Biotechnology Sector in The United States and China
- Industry report
- August 2011
- 14 pages
... Are the most popular host system for the production of bio- therapeutics in the biotechnology and pharmaceu- tical industries [1]. Currently, 60 70% Of all recom- binant biotherapeutics are produced in cho cells ...
- Industries: Biotechnology
- Countries: United States, China
The Chinese Biopharmaceutical Business Brief
- Industry report
- December 2011
- 7 pages
... Perspectives on partnering to capture china S biosimilar/ biologics opportunities Can biotherapeutics sales growth trend continue on a larger scale Which domestic players are leaders today and can ...
- Industries: Biopharmaceutical
- Countries: China
Blood Sector in Canada
- Industry report
- April 2012
- 3 pages
... Products manufactured by grifols (formerly talecris biotherapeutics), csl behring and baxter corporation to meet the expected demand for this year. Purchasing immune globulin products from multiple ...
- Industries: Blood Supply, Tissue Banking and Transplantation
- Countries: Canada
The Indian Biogeneric Sector Brief
- Industry report
- October 2011
- 6 pages
... To produce biotherapeutics in an emerging country such as india is often one of the greatest limiting factors. This is primarily due to complications related to manufacturing biologics as well as issues ...
- Industries: Biopharmaceutical
- Countries: India
The South Korean Biosimilar Sector
- Industry report
- May 2011
- 21 pages
- by Intergovernmental Agency
... Explained the scope and important key definitions such as sbp, reference biotherapeutic products (rbp) and the importance of using appropriate terminology. The guideline advocates the principle of a step ...
- Industries: Biopharmaceutical
- Countries: South Korea
» Read our Company Profiles
2 Companies for BiotherapeuticBig Island Tropical Flower Farms
United StatesCitrix
United StatesReportlinker.com © Copyright 2013. All rights reserved.
